We’re upgrading our website to improve your online experience!
While we make these exciting changes, shopping cart and online
ordering will be temporarily offline. A brand-new
IFA.coop
is coming soon. In the meantime, please visit your hometown IFA
Country Store for all the IFA products you love. Thanks for your patience.
TETANUS TOXOID aids in the prevention of tetanus, a potentially fatal equine bacterial disease caused by Clostridium tetani. Tetanus toxoid is considered a core equine vaccine by the American Association of Equine Practitioners and all horses should receive annual vaccination. The tetanus bacteria can be present in the intestinal tract and feces of horses, other animals and humans. It can be abundant in the soil, with bacterial spores able to survive in the environment for years, creating a continuous risk for horses and people. Transmission can occur through puncture wounds, open lacerations, exposed tissue and surgical incisions.
Monovalent vaccine to aid in the prevention of tetanus
TETANUS TOXOID is adjuvant with MetaStim®, which enhances the horse's immune response and promotes the proper rate of vaccine absorption following inoculation
Protective tetanus antibody titers typically occur two weeks after the second injection of the initial series
Inject one 1 mL dose intramuscularly using aseptic technique
Administer a second 1 mL dose 4 to 8 weeks after the first dose
A 1 mL booster dose should be given annually
In the event of injury during the initial vaccination program or if annual boosters have not been given, a prophylactic dose of at least 1500 units of tetanus antitoxin should be given
Temporary local reactions at the injection site may occur
In case of anaphylactoid reaction, administer epinephrine